Climate-Driven Mosquito Season Shifts Earlier, Threatening Disease Spread Across Northern Regions

Warming temperatures are advancing mosquito emergence by 1–2 weeks in northern temperate regions, extending the transmission season for vector-borne diseases…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

UK National Screening Committee Defends Stance Against Routine Prostate Cancer Screening

UK's National Screening Committee publishes detailed position statements defending evidence-based approach to prostate cancer screening decisions. New guidance addresses multicancer…

SERPINA12 Gene Mutations Identified as New Cause of Hereditary Palmoplantar Keratoderma

Researchers identify SERPINA12 gene mutations as a novel cause of hereditary palmoplantar keratoderma. The discovery expands genetic testing options for…

New ACA Rule Allows 30% Higher Deductibles While Expanding Plan Options

Trump administration finalizes ACA rule allowing 30% higher out-of-pocket costs while introducing network-free plan options. New regulation expands consumer choice…

Healthcare Professionals Break Barriers Around Women’s Health Taboos in Open Discussion Event

Three nurses organize community events to address taboo women's health topics, creating safe spaces for open healthcare discussions. The initiative…

Pediatrician calls for clinical trials to evaluate AI tools for children’s development

Pediatrician Dr. Dua Hassan calls for randomized controlled trials to evaluate AI tools for children, emphasizing developmental outcomes over engagement…

Autism Stigma in South Asian American Families Creates Barriers to Care, Psychiatrist Warns

Cultural stigma in South Asian American families creates unique barriers to autism care access. Psychiatrist highlights how family crisis responses…

Reversing Prediabetes Cuts Cardiovascular Death Risk by 58%, Long-term Studies Show

New research shows people who reverse prediabetes by normalizing blood sugar levels reduce their risk of cardiovascular death by 58%…

New Interferon Treatment Shows Promise for Essential Thrombocythemia Across All Genetic Variants

New North American study shows ropeginterferon alfa-2b-njft achieved 61% complete response rate in essential thrombocythemia patients across all genetic variants.…

GMJ BriefsView all →
© 2026 GMJ News · PHIG · Sheni Network